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Abstract: Most of the snakebites recorded in Brazil are caused by the Bothrops genus. Given that the 
local tissue damage caused by this genus cannot be treated by antivenom therapy, numerous studies are 
focusing on supplementary alternatives, such as the use of medicinal plants. Serjania erecta has already 
demonstrated anti-inflammatory, antiseptic and healing properties. In the current study, the aerial parts of 
S. erecta were extracted with methanol, then submitted to chromatographic fractionation on a Sephadex 
LH20 column and eluted with methanol, which resulted in four main fractions. The crude extract and 
fractions neutralized the toxic activities of Bothrops jararacussu snake venom and isolated myotoxins 
(BthTX-I and II). Results showed that phospholipase A2, fibrinogenolytic, myotoxic and hemorrhagic activities 
were inhibited by the extract. Moreover, the myotoxic and edematous activities induced by BthTX-I, and 
phospholipase A2 activity induced by BthTX-II, were inhibited by the extract of S. erecta and its fraction. The 
clotting time on bovine plasma was significantly prolonged by the inhibitory action of fractions SF3 and 
SF4. This extract is a promising source of natural inhibitors, such as flavonoids and tannins, which act by 
forming complexes with metal ions and proteins, inhibiting the action of serineproteases, metalloproteases 
and phospholipases A2.  
Key words: medicinal plants, antiophidian properties, Serjania erecta, Bothrops jararacussu snake venom, 
myotoxins.
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INTRODUCTION
Snake venoms are a complex mixture of toxic 
enzymes and proteins such as phospholipases 
A2, myotoxins, hemorrhagic metalloproteases, 
clotting serineproteases, neurotoxins, cytotoxins 
and others. In Brazil, Bothrops and Crotalus snakes 
are responsible for most ophidian envenomations, 
which induce mainly local tissue damage such as 
hemorrhage, necrosis, edema and alterations in 
blood coagulation. Snakebite envenomations are 
frequently treated with parenteral administration 
of horse- or sheep-derived antivenoms aiming 
at the neutralization of toxins. But despite the 
success of serum therapy, it is important to search 
for different venom inhibitors, either synthetic 
or natural, which would complement the action 
of antivenoms, particularly in relation to the 
neutralization of local tissue damage (1). Plant 
extracts constitute an extremely rich source 
of pharmacologically active compounds, and 
a number of extracts has been shown to act 
against snake venom (2). The medicinal value 
associated with a plant can be confirmed by the 
successful use of its extract on snakebite wounds 
(3-6). Application of medicinal plants with anti-
snake-venom activities might be useful as first 
aid treatment for victims of snakebites, which 
is particularly important in local areas where 
antivenoms are not readily available (7-10).
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In many countries, plant extracts have been 
used traditionally in the treatment of snakebite 
envenomations. Thus, vegetal extracts have been 
found to constitute an excellent alternative with a 
range of anti-snake-venom properties. However, in 
most cases, scientific evidence of their antiophidian 
activity is still needed. Several plants have already 
shown antiophidian activity and the Brazilian flora 
has a wide variety of medicinal plants with anti-
snake-venom potential (2, 3, 5, 6, 11).  
The vegetal kingdom is the main source of 
pharmacologically active compounds (12). The 
Sapindaceae family is widely distributed in the 
tropical regions of the world and some species 
are found in Brazil, including Serjania erecta 
Radlk, commonly called retrato de teiú, cinco-
folhas or cipó-cinco-folhas (13). The popular use 
of S. erecta in Brazil is related to the treatment 
of inflammatory and ulcerative diseases, but 
several studies showed that different species of 
the Serjania genus and some of their isolated 
compounds present analgesic, antibacterial, 
antifungal, molluscicidal activity and anti-
inflammatory effect (14-17). Phytochemical 
screening tests have demonstrated the presence 
of alkaloids, saponins, flavonoids, tannins, 
triterpenoids, steroids, catechins, coumarins, 
anthranoids and quinines in S. erecta extract (16). 
The present study aimed to investigate the healing 
properties of S. erecta against the toxic effects 
induced by Bothrops jararacussu snake venom. 
MATERIALS AND METHODS
Reagents and Animals
Snake venoms were purchased from the 
Bioactive Proteins Serpentarium, Batatais, São 
Paulo state, Brazil. BthTX-I and II were isolated 
from Bothrops jararacussu snake venom (Bjussu) 
as previously described (18). Male Swiss mice (18-
25 g) were obtained from the animal house at the 
School of Pharmaceutical Sciences of Ribeirão 
Preto, São Paulo state, Brazil. Experiments 
reported in this study were performed after 
approval by the Institutional Ethics Committee 
of the University of São Paulo (protocol n. 
07.1.202.53.1).
Plant Material and Chromatographic 
Fractionation
Plant material of Serjania erecta was collected 
in Altinópolis (from a rural area in the state of 
São Paulo). A voucher specimen (n. HPMU 
835) has been deposited at the Medicinal 
Plant Herbarium of the Biotechnology Unit of 
the University of Ribeirão Preto (UNAERP), 
Ribeirão Preto, SP, Brazil. Aerial parts (stem and 
leaf) were dried in an oven at 60°C and plant 
material was pulverized into a dry powder and 
extracted by applying methanol for three days by 
maceration. The extract was then concentrated at 
a reduced temperature (50°C). The crude extract 
(5 g) was dissolved in methanol and subjected to 
chromatographic fractionation on a Sephadex 
LH20 column (110 x 3 cm) and eluted with 
methanol. This fractionation resulted in four main 
fractions that were evaluated by phytochemical 
screening tests. The fractions were evaporated 
under reduced pressure and the concentrations 
were expressed in terms of dry weight. 
Phospholipase A2 Activity
Phospholipase A2 activity was measured via an 
indirect hemolytic assay on agarose-erythrocyte-
egg yolk gel plates, following methods described 
by Gutiérrez et al. (19). The minimum indirect 
hemolytic dose (MIHD) of BthTX-II or B. 
jararacussu snake venom (10 μg) induced 
hemolytic halos after incubation of plates for 18 
hours at 37°C. The extracts and venom/toxin 
(1:30, w/w) were preincubated for 30 minutes at 
37°C and the anti-phospholipase A2 potential of 
the extracts was measured after 18 hours of plate 
incubation at 37°C. This experiment was done in 
triplicate. Crude venom and phosphate buffered 
saline (PBS) were used as controls.
Fibrinogenolytic Activity
The fibrinogenolytic activity was evaluated as 
previously described (20). Bovine fibrinogen (40 
µg) was incubated at 37°C for one hour with 10 µg 
of B. jararacussu snake venom preincubated with 
the extracts (1:30, w/w) for 30 minutes at 37°C 
and the reaction was stopped with 25 μL of 0.5M 
Tris-HCl buffer (pH 6.5) containing 2% (w/v) 
SDS, 3.5% (v/v) β-mercaptoethanol and 0.05 
% (w/v) bromophenol blue. The samples were 
analyzed by 12% (w/v) sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). 
Edema-Inducing Activity
Edema was evaluated by subplantar injection 
of BthTX-I (10 µg) in the right paw of male Swiss 
mice (18-25 g, n = 5). Inhibition studies were 
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performed after preincubation of venom/toxin 
with the extracts at a 1:30 (w/w) ratio. Control 
animals received an injection of PBS under 
identical conditions. The progression of edema 
was evaluated by measuring the paw with a low-
pressure pachymeter (Mitutoyo, Japan) at four 
time intervals (0, 30, 60 and 180 minutes) upon 
and after injection (21). Activity was expressed as 
the mean of percent edema values induced by the 
snake venoms in the absence and presence of the 
plant extracts and their fractions.
Myotoxic Activity
Male Swiss mice (18-25 g, n = 5) were injected 
intra-muscularly (IM) in the right gastrocnemius 
muscle with samples containing doses of 10 µg of 
BthTX-I or B. jararacussu snake venom. Following 
incubation of S. erecta methanolic extract and 
fractions with the crude venoms or isolated toxins 
for 30 minutes at 37°C, the mixtures of myotoxin/
inhibitors (1:30, w/w) were then evaluated. 
Controls received venom/toxin. Mice were bled 
from the tail three hours after injections and 
blood was collected into heparinized capillary 
tubes. Plasma creatine kinase (CK) activity was 
determined using the kit CK-UV (Bioclin, Brazil) 
(22). The myotoxic activity was expressed in U/L. 
Hemorrhagic Activity
Hemorrhagic activity was assessed according to 
the method of Gutiérrez et al. (23). The minimum 
hemorrhagic dose (MHD) of B. jararacussu snake 
venom (10 μg) was determined by intradermal 
(ID) injection into marked positions on the 
shaved dorsal skin of mice (18-25g, n = 5). The 
inhibition of hemorrhagic activity was assayed 
by ID injection of venom preincubated with 
the extracts (30 minutes at 37°C, 1:30, w/w) in 
the back of mice. After three hours, mice were 
sacrificed with CO2, the dorsal skin was removed 
and the diameter of the hemorrhagic lesion 
on the inner surface of the skin was measured. 
Hemorrhagic activity was expressed as the mean 
of the hemorrhagic halos (in mm). Crude venom 
was used as control.
Coagulant Activity
A minimum coagulant dose (MCD) was 
defined as the amount of B. jararacussu venom 
that clots 200 µL of bovine plasma in 120 seconds 
(24). Briefly, 200 µL aliquots of plasma (n = 3) 
were incubated with 20 µg of venom preincubated 
with the extracts (30 minutes at 37°C, 1:30, w/w) 
and clotting times were recorded. Control tubes 
included plasma with PBS plus calcium, extracts/
fractions alone and with venom. Coagulant 
activity was expressed as the mean coagulation 
time (in minutes) induced by the snake venom 
in the absence and presence of extracts and 
fractions.
Statistical Analysis
The statistical significance of differences 
between groups was evaluated using one-way 
analysis of variance (ANOVA). A p-value < 0.05 
was considered significant. Data are shown as 
mean ± standard deviation (SD).
RESULTS AND DISCUSSION
The fractionation of methanolic extract of S. 
erecta (EFMeOH) on Sephadex LH20 resulted 
in four main fractions: SF1 (18.2%), SF2 (42%), 
SF3 (19.6%) and SF4 (16.2%). These fractions 
were subjected to phytochemical screening tests 
that revealed the presence of saponins, terpenes, 
flavonoids and tannins, respectively (results not 
shown). 
Phospholipases A2 (PLA2s) constitute one 
of the widely distributed enzyme groups that 
hydrolyze glycerophospholipids at the sn-2 
position of the glycerol backbone, thus releasing 
lysophospholipids and fatty acids. Snake venom 
PLA2s are known to induce various pathological 
effects in experimental animal models. PLA2 
activity induced by B. jararacussu snake venom 
(Figure 1 – A) and myotoxin BthTX-II (Figure 
1 – B) were inhibited at different levels by the 
methanolic extract of S. erecta and its fractions. 
For example, the PLA2 activity induced by BthTX-
II was almost completely inhibited by the action 
of fractions SF3 and SF4. The SF3 fraction is rich 
in flavonoids, compounds known to possess anti-
inflammatory activity, while the SF4 fraction is 
rich in tannins, a class of compounds that can 
precipitate proteins. The fact that the fractions 
SF3 and SF4 have shown a greater efficiency in the 
inhibition of BthTX-II-induced PLA2 activity and 
lesser action against the PLA2 activity induced 
by crude venom may be related to the presence 
of other toxic components in the venom, which 
are also responsible for this activity. Several 
exogenous agents from medicinal plants such as 
flavonoids, aristolochic acid and coumestan are 
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Figure 1. Inhibition of the PLA2 activity by the methanolic extract of S. erecta and its fractions at 1:30 ratio 
(venom/toxin:inhibitor, w/w). (A) Effect of extracts on the PLA2 activity induced by B. jararacussu crude 
venom (10 µg). (B) Effect of extracts on the PLA2 activity induced by BthTX-II, an Asp49-PLA2 (10 µg). The 
total activity of each venom or PLA2 alone was considered to be 100%. Results are expressed as the mean 
± SD (n = 3). * p < 0.05 and ** p < 0.01, when compared to control activity.
Figure 2. (A) SDS-PAGE of the proteolytic activity of B. jararacussu venom with and without S. erecta extracts 
upon bovine fibrinogen. Lanes: 1, fibrinogen control (40 µg); 2, fibrinogen + Bjussu; 3, fibrinogen + Bjussu 
+ EFMeOH; 4, fibrinogen + Bjussu + SF1; 5, fibrinogen + Bjussu + SF2; 6, fibrinogen + Bjussu + SF3; 7, 
fibrinogen + Bjussu + SF4. The B. jararacussu snake venom (10 µg) was preincubated with the extracts for 30 
minutes at 37°C (1:30, w/w). (B) Inhibition of the edema-inducing activity of BthTX-I by methanolic extract 
of S. erecta and its fractions. BthTX-I (10 µg) was preincubated with the extracts for 30 minutes at 37°C (1:30, 
w/w). Results are expressed as mean ± SD (n = 5). * p < 0.05, when compared to control activity.
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Figure 3. (A) Inhibition of the myotoxic activity induced by B. jararacussu crude venom (10 µg) by the 
methanolic extract of S. erecta and its fractions. (B) Inhibition of the myotoxic activity induced by myotoxin 
BthTX-I (10 µg) by the methanolic extract of S. erecta and its fractions. (C) Inhibition of the hemorrhagic 
activity of B. jararacussu crude venom (10 µg) by the methanolic extract of S. erecta and its fractions. Venom/
toxin was preincubated with the extracts for 30 minutes at 37°C (1:30, w/w). Results are expressed as mean 
± SD (n = 5). * p < 0.05 and ** p < 0.01, when compared to control activity.
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also known to inhibit PLA2 activity (3, 25, 26). 
Some compounds from snake venoms show 
large diversity in their proteolytic activity and 
fibrinogen is one of their main substrates. These 
proteases can convert fibrinogen into fibrin. 
Once again, fractions SF3 and SF4 were capable 
of preventing the complete degradation of the 
fibrinogen chains (Figure 2 – A). The fractions 
effectively antagonized the defibrinogenating 
activity induced by B. jararacussu snake venom. 
Previously studied plant extracts also revealed 
efficient results in the protection of fibrinogen, 
including Bauhinia forficata (27), Citrus limon 
and Ficus nymphaeifolia (4, 9).
The formation of mast-cell-mediated 
edema in the presence of PLA2s is the result of 
enzymatic activity. Nevertheless, venom PLA2s 
with no enzymatic activity activate mast cells by 
an independent mechanism of catalytic activity 
(28). In assays of the edema-inducing activity 
(Figure 2 – B), the methanolic extract of S. erecta 
and its fractions inhibited BthTX-I diminishing 
the formation of edema. Other plant extracts 
also inhibited the formation of edema-inducing 
activity, such as Mandevilla velutina, Cordia 
verbanacea, Mikania glomerata  and Blutaparon 
portulacoides (29-32).
Local tissue damage induced by Bothrops 
venoms is caused by hemorrhage, proteolysis, 
myonecrosis and edema. Myotoxic activity 
is the result of the action of hemorrhagic 
metalloproteases or myotoxic PLA2s (33). The 
myotoxicity induced by B. jararacussu snake 
venom (Figure 3 – A) and its isolated myotoxin, 
BthTX-I (Figure 3 – B), was significantly decreased 
by preincubation with the methanolic extract of 
S. erecta and its fractions. Some medicinal plants 
with antiophidian activity also showed promising 
results in the inhibition of myonecrosis induced 
by snake venom, including Calendula officinalis 
(34) and Tabernaemontana catharinensis (35).
The methanolic extract of S. erecta and its 
fractions decreased the hemorrhagic activity 
induced by B. jararacussu venom (Figure 3 – C). 
One of the most beneficial first-aid treatments 
in viperid snakebites is the neutralization of 
hemorrhagic symptoms. These results suggest 
an interaction between the extract components 
and metalloproteases, which inhibited their 
hemorrhagic activities. Antiophidian plants with 
antihemorrhagic properties have been identified 
in different studies as Calendula officinalis, 
Baccharis trimera, Mikania glomerata, Casearia 
sylvestris and Eclipta alba (26, 31, 34, 36, 37).
Bothrops venom usually produces hemorrhages 
due to a considerable degradation of fibrinogen 
and other clotting factors which prevents clot 
formation (1). The methanolic extract of S. erecta 
and its fractions were able to delay the clotting 
time of citrated plasma after addition of the 
venoms at a 1:30 ratio, but fractions SF3 and SF4 
were more efficient in that, since they considerably 
inhibited the coagulant activity of B. jararacussu 
venom (Table 1). Results with fractions SF3 and 
SF4, rich in flavonoids and tannins, showed that 
these compounds act as powerful inhibitors of 
the hemorrhagic and clotting activity, probably 
due to interaction with metalloproteases and 
thrombin-like enzymes, respectively. Studies of 
several plants (Heliconia curtispatha, Pleopeltis 
Table 1. Inhibition of the coagulant activity of B. jararacussu venom (20 µg) by the methanolic extract of S. 
erecta and its fractions, preincubated at 1:30 (w/w) ratio for 30 minutes at 37°C
Samples Coagulant activity (min) Sample Coagulant activity (min)
B. jararacussu 1 min 20 s ± 0.03 PBS + Ca+2 5 min 15 s ± 0.03
B. jararacussu + EFMeOH 1 min 30 s ± 0.02 EFMeOH 2 min 43 s ± 0.04
B. jararacussu + SF1 1 min 50 s ± 0.03 * SF1 1 min 42 s ± 0.02
B. jararacussu + SF2 1 min 36 s ± 0.03 SF2 2 min 30 s ± 0.02
B. jararacussu + SF3 > 50 min ** SF3 > 50 min
B. jararacussu + SF4 > 50 min ** SF4 > 50 min
Results are expressed as mean ± SD (n = 3). * p < 0.05 and ** p < 0.01, when compared to control activity.
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percussa, Brownea rosademonte, Bixa orellana, 
Trichomanes elegans, Struthanthus orbiculareis 
and Casearia sylvestris) describe the inhibitory 
effect of all or part of the coagulant activity of 
snake venoms from B. asper, B. jararacussu, B. 
pirajai, B. neuwiedi, B. moojeni and C. d. terrificus 
(9, 38, 39).
CONCLUSION
Ophidian accidents caused by Bothrops 
snakes are characterized by prominent local 
tissue damage due to myonecrosis, hemorrhage 
and edema, and unfortunately antivenoms are 
unable to antagonize the myotoxic effects of 
phospholipase myotoxins or the hemorrhagins 
in the venom (1). Vegetal extracts have served 
as alternatives for treatment or as an additional 
therapy for local tissue damage, since they are 
sources of chemical compounds with several 
pharmacological activities of medical-scientific 
interest. Folk medicine shows several examples of 
claimed medicinal plants including the popular 
use of S. erecta for treating inflammatory and 
ulcerative diseases. Possibly its antiophidian 
activity is due to the presence of phenolic 
compounds such as flavonoids and tannins. 
These compounds present the ability to inhibit 
toxic activities of B. jararacussu snake venom and 
the isolated myotoxins BthTX-I and II. Other 
studies were also able to demonstrate the role 
of phenolic compounds in inhibiting the effects 
of snake venoms (40-42). Furthermore, possible 
isolated compounds can be used as molecular 
models of inhibitors for the development of 
new therapeutic agents in treatment of ophidian 
accidents. This extract is a promising source of 
natural inhibitors, such as flavonoids and tannins, 
which probably act by forming complexes with 
metal ions and proteins that inhibit the action of 
serine proteases involved in blood coagulation 
disturbances and metalloproteases responsible 
for hemorrhagic processes and enzymatic activity 
of phospholipases A2.  
ACKNOWLEDGEMENTS
The authors are grateful for the financial 
support provided by the Coordination for the 
Improvement of Higher Education Personnel 
(CAPES), the National Council for Scientific and 
Technological Development (CNPq) and the State 
of São Paulo Research Foundation (FAPESP); 
and for the technical assistance of all students 
and technicians (Fernanda Romano Suzano and 
Sarazate I. V. Pereira) who collaborated in this 
work. The authors also thank the University of 
Ribeirão Preto.
COPYRIGHT
© CEVAP 2011
SUBMISSION STATUS
Received: October 29, 2010.
Accepted: January 25, 2011.
Abstract published online: January 26, 2011.
Full paper published online: February 28, 2011.
CONFLICTS OF INTEREST
There is no conflict.
FINANCIAL SOURCE
The Coordination for the Improvement of 
Higher Education Personnel (CAPES), the 
National Council for Scientific and Technological 
Development (CNPq) and the State of São Paulo 
Research Foundation (FAPESP) provided the 
financial grants.
ETHICS COMMITTEE APPROVAL
The present study was approved by the 
Institutional Ethics Committee of the University 
of São Paulo (protocol number 07.1.202.53.1)
CORRESPONDENCE TO
RENATA S. FERNANDES, Departamento de 
Análises Clínicas, Toxicológicas e Bromatológicas, 
Faculdade de Ciências Farmacêuticas de Ribeirão 
Preto, Universidade de São Paulo, Ribeirão Preto, 
SP, Brasil. Phone: +55 16 3602 4714. Email: 
renatarsf@usp.br.
REFERENCES
1. Cardoso JLC, França FOS, Wen FH, Malaque 
CMS, Haddad Jr V. Animais peçonhentos 
no Brasil: biologia, clínica e terapêutica dos 
acidentes. São Paulo: Ed. Sarvier, 2003. 468 p.
2. Martz W. Plants with a reputation against 
snakebite. Toxicon. 1992;30(10):1131-42.
3. Mors WB, Nascimento MC, Pereira BM, Pereira 
NA. Plant natural products active against snake 
bite – the molecular approach. Phytochemistry. 
2000;55(6):627-42.
4. Otero R, Fonnegra R, Jiménez SL, Núñes V, Evans 
N, Alzate SP, et al. Snakebites and ethnobotany 
in the northwest region of Colombia. Part I: 
Fernandes RS, et al. Neutralization of Bothrops jararacussu snake venom by Serjania erecta extract
J Venom Anim Toxins incl Trop Dis  |  2011  |  volume 17  |  issue 1 92
traditional use of plants. J Ethnopharmacol. 
2000;71(3):493-504.
5. Soares AM, Januário AH, Lourenço MV, 
Pereira AMS, Pereira PS. Neutralizing effects of 
Brazilian plants against snake venoms. Drugs Fut. 
2004;29(11):1105-17.
6. Soares AM, Marcussi S, Fernandes RS, Menaldo 
DL, Costa TR, Lourenço MV, et al. Medicinal 
plant extracts and molecules as the source of 
new anti-snake venom drugs. In: Rahman A, 
Reitz AB, Choudhary MI, editors. Frontiers in 
medicinal chemistry. Karachi-Pakistan: Bentham 
Science Publishers; 2009. 309-46 p. 4 vol. 
7. Otero R, Núñez V, Jiménez SL, Fonnegra R, Osorio 
RG, García ME, et al. Snakebites and ethnobotany 
in the northwest region of Colombia. Part II: 
neutralization of lethal and enzymatic effects 
of Bothrops atrox venom. J Ethnopharmacol. 
2000;71(3):505- 11.
8. Otero R, Núñez V, Borona J, Fonnegra R, Jiménez 
SL, Osório RG, et al. Snakebites and ethnobotany 
in the northwest region of Colombia. Part III: 
neutralization of haemorrhagic effect of Bothrops 
atrox venom. J Ethnopharmacol. 2000;73(1-
2):233-41.
9. Núñez V, Otero R, Barona J, Saldarriaga M, 
Osório RG, Fonnegra R, et al. Neutralization of 
the edema-forming, defibrinating and coagulant 
effects of Bothrops asper venom by extracts of 
plants used by healers in Colombia. Braz J Med 
Biol Res. 2004;37(7):969-77. 
10. Sánchez EE, Rodríguez-Acosta A. Inhibitors 
of snake venoms and development of 
new therapeutics. Immunopharmacol 
Immunotoxicol. 2008;30(4):647-78.
11. De Paula RC, Sanchez EF, Costa TR, Martins 
CHG, Pereira PS, Lourenço MV, et al. 
Antiophidian properties of plant extracts against 
Lachesis muta venom. J Venom Anim Toxins incl 
Trop Dis. 2010;16(2):311-23. 
12. Cordell GA, Colvard MD. Some thoughts on the 
future of ethnopharmacology. J Ethnopharmacol. 
2005;100(1-2):5-14.
13. Guarim-Neto G, Santana SR, Silva JVB. Notas 
etnobotânicas de espécies de Sapindaceae jussieu. 
Acta Bot Bras. 2000;14(3):327-34.
14. di Stasi LC, Costa M, Mendaçolli SL, Kirizawa M, 
Gomes C, Trolin G. Screening in mice of some 
medicinal plants used for analgesic purposes 
in the state of São Paulo. J Ethnopharmacol. 
1988;24(2-3):205-11.
15. Ekabo OA, Farnsworth NR, Henderson TO, Mao 
G, Mukherjee R. Antifungal and molluscicidal 
saponins from Serjania salzmanniana. J Nat 
Prod. 1996;59(4):431-5.
16. de Lima MR, de Souza Luna J, dos Santos AF, de 
Andrade MC, Sant’ana, AE, Genet JP, et al. Anti-
bacterial activity of some Brazilian medicinal 
plants. J Ethnopharmacol. 2006;105(1-2):137-47.
17. Gomig F, Pietrovski EF, Guedes A, Dalmarco 
EM, Calderari MT, Guimarães CL, et al. Topical 
anti-inflammatory activity of Serjania erecta 
Radlk (Sapindaceae) extracts. J Ethnopharmacol. 
2008;118(2):220-4.
18. Andrião-Escarso SH, Soares AM, Rodrigues 
VM, Ângulo Y, Díaz C, Lomonte B, et al. 
Myotoxic phospholipases A2 in Bothrops snake 
venoms: effect of chemical modifications on 
the enzymatic and pharmacological properties 
of bothropstoxins from Bothrops jararacussu. 
Biochimie. 2000;82(8):755-63.
19. Gutiérrez JM, Avila C, Rojas E, Cerdas L. An 
alternative in vitro method for testing the potency 
of the polyvalent antivenom produced in Costa 
Rica. Toxicon. 1988;26(4):411-3.
20. Rodrigues VM, Soares AM, Guerra-Sá 
R, Rodrigues V, Fontes MRM, Giglio JR. 
Structural and functional characterization of 
neuwiedase, a nonhemorrhagic fibri(ogen)olytic 
metalloprotease from Bothrops neuwiedi snake 
venom. Arch Biochem Biophys. 2000;381(2):213-
24.
21. Soares AM, Andrião-Escarso SH, Angulo Y, 
Lomonte B, Gutiérrez JM, Marangoni S, et 
al. Structural and functional characterization 
of a myotoxin I, a Lys49 phospholipase A(2) 
homologue from Bothrops moojeni (caissaca) 
snake venom. Arch Biochem Biophys. 
2000;373(1):7-15. 
22. Soares AM, Andrião-Escarso SH, Bortoleto RK, 
Rodrigues-Simioni L, Ward RJ, Arni RK, et al. 
Dissociation of enzymatic and pharmacological 
activities of two piratoxins-I and -III, two 
myotoxic phospholipases A2, from Bothrops 
pirajai snake venom. Arch Biochem Biophys. 
2001;387(2):188-96.
23. Gutiérrez JM, Gené JA, Rojas G, Cerdas L. 
Neutralization of proteolytic and hemorrhagic 
activities of Costa Rica snake venoms by a 
polyvalent antivenom. Toxicon. 1985;23(6):887-
93.
24. Gené JA, Roy A, Rojas G, Gutiérrez JM, Cerdas L. 
Comparative study on coagulant, defibrinating, 
fibrinolytic and fibrinogenolytic activities of 
Costa Rican crotaline snake venoms and their 
neutralization by a polyvalent antivenom. 
Toxicon. 1989;27(8):841-8.
25. Vishwanath BS, Gowda TV. Interaction 
of aristolochic acid with Vipera russelli 
phospholipase A2: its effect on enzymatic 
and pathological activities. Toxicon. 
1987;25(9):929-37.
Fernandes RS, et al. Neutralization of Bothrops jararacussu snake venom by Serjania erecta extract
J Venom Anim Toxins incl Trop Dis  |  2011  |  volume 17  |  issue 1 93
26. Diogo LC, Fernandes RS, Marcussi S, Menaldo 
DL, Roberto PG, Matrangulo PV, et al. Inhibition 
of snake venoms and phospholipases A2 by 
extracts from native and genetically modified 
Eclipta alba: isolation of active coumestans. Basic 
Clin Pharmacol Toxicol. 2009;104(4):293-9. 
27. Oliveira CZ, Maiorano VA, Marcussi S, 
Sant’Ana CD, Januário AH, Lourenço MV, 
et al. Anticoagulant and antifibrinogenolytic 
properties of the aqueous extract from Bauhinia 
forficata against snake venoms. J Ethnopharmacol. 
2005;98(1-2):213-6. 
28. Marcussi S, Sant’Ana CD, Oliveira CZ, Rueda 
AQ, Menaldo DL, Beleboni RO, et al. Snake 
venom phospholipase A2 inhibitors: medicinal 
chemistry and therapeutic potential. Curr Top 
Med Chem. 2007;7(8):743-56. 
29. Biondo R, Pereira AM, Marcussi S, Pereira PS, 
França SC, Soares AM. Inhibition of enzymatic 
and pharmacological activities of some snake 
venoms and toxins by Mandevilla velutina 
(Apocinaceae) aqueous extract. Biochimie. 
2003;85(10):1017-25. 
30. Ticli FK, Hage LI, Cambraia RS, Pereira PS, Magro 
AJ, Fontes MR, et al. Rosmarinic acid, a new 
snake venom phospholipases A2 inhibitor from 
Cordia verbenacea (Boraginaceae): antiserum 
action potentiation and molecular interaction. 
Toxicon. 2005;46(3):318-27. 
31. Maiorano VA, Marcussi S, Daher MA, Oliveira 
CZ, Couto LB, Gomes OA, et al. Antiophidian 
properties of the aqueous extract of Mikania 
glomerata. J Ethnopharmacol. 2005;102(3):364-
70.
32. Pereira IC, Barbosa AM, Salvador MJ, Soares 
AM, Ribeiro W, Cogo JC, et al. Anti-inflamatory 
activity of Blutaparon portulacoides ethanolic 
extract against the inflammatory reaction 
induced by Bothrops jararacussu venom and 
isolated myotoxins BthTX-I and II. J Venom 
Anim Toxins incl Trop Dis. 2009;15(3):527-45. 
33. Gutiérrez JM, Lomonte B. Phospholipase A2 
myotoxins from Bothrops snake venoms. In: 
Venom phospholipase A2 enzymes: structure, 
function, and mechanism. England, UK: John 
Wiley & Sons, 1997. 321-52 p.
34. Melo MM, Merfort I, Habermehl GG, Ferreira 
KM. Uso de extratos de plantas no tratamento 
local de pele de coelho após envenenamento 
botrópico experimental. J Bras Fitomed. 
2003;1(1):100-6. 
35. Veronese EL, Esmeraldino LE, Trombone AP, 
Santana AE, Bechara GH, Kettelhut I, et al. 
Inhibition of the myotoxic activity of Bothrops 
jararacussu venom and its two major myotoxins, 
BthTX-I and BthTX-II, by the aqueous extract 
of Tabernaemontana catharinensis A. DC. 
(Apocynaceae). Phytomedicine. 2005;12(1-
2):123-30. 
36. Januário AH, Marcussi S, Santos SL, Mazzi MV, 
Sampaio SV, Pietro RC, et al. Neo-clerodane 
diterpenoid, a new metalloprotease snake venom 
inhibitor from Baccharis trimera (Asteradeae): 
anti-proteolytic and anti-hemorrhagic properties. 
Chem Biol Interact. 2004;150(3):243-51. 
37. Cavalcante WL, Campos TO, Dal Pai-Silva 
M, Pereira PS, Oliveira CZ, Soares AM, et al. 
Neutralization of snake venom phospholipase A2 
toxins by aqueous extract of Casearia sylvestris 
(Flacourtiaceae) in mouse neuromuscular 
preparation. J Ethnopharmacol. 2007;112(3):490-
7. 
38. Borges MH, Soares AM, Rodrigues VM, 
Andrião-Escarso SH, Diniz H, Hamaguchi A, et 
al. Effects of aqueous extract of Casearia sylvestris 
(Flacourtiaceae) on actions of snake and bee 
venoms and on activity of phospholipases A2. 
Comp Biochem Physiol B Biochem Mol Biol. 
2000;127(1):21-30.
39. Borges MH, Soares AM, Rodrigues VM, 
Oliveira F, Franshechi AM, Rucavado A, et 
al. Neutralization of proteases from Bothrops 
snake venoms by the aqueous extract from 
Casearia sylvestris (Flacourtiaceae). Toxicon. 
2001;39(12):1863-9.
40. Pithayanukul P, Ruenraroengsak P, Bavovada R, 
Pakmanee N, Suttisri R, Saen-oon S. Inhibition 
of Naja kaouthia venom activities by plant 
polyphenols. J Ethnopharmacol. 2005;97(3):527-
33.
41. Samy RP, Thwin MM, Gopalakrishnakone P, 
Ignacimuthu S. Ethnobotanical survey of folk 
plants for the treatment of snakebites in Southern 
part of Tamilnadu, India. J Ethnopharmacol. 
2008;115(2):302-12.
42. Nishijima CM, Rodrigues CM, Silva MA, Lopes-
Ferreira M, Vilegas W, Hiruma-Lima CA. Anti-
hemorrhagic activity of four Brazilian vegetable 
species against Bothrops jararaca venom. 
Molecules. 2009;14(3):1072-80.
